Loss of imprinting in disease progression in chronic myelogenous leukemia

Blood

Volumn 91, Issue 9, 1998, Pages 3144-3147

  Randhawa, Gurvaneet S ^b   Cui, Hengmi ^b   Barletta, Janet A ^b   Strichman Almashanu, Liora Z ^b   Talpaz, Moshe ^b   Kantarjian, Hagop ^b   Deisseroth, Albert B ^b   Champlin, Richard C ^b   Feinberg, Andrew P ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B;

ALLELE; ARTICLE; CHRONIC MYELOID LEUKEMIA; DISEASE COURSE; GENETIC SCREENING; GENOME IMPRINTING; HUMAN; LEUKEMOGENESIS; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

EID: 0032080161     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.9.3144.3144_3144_3147     Document Type: Article

References (26)

1. Nowell PC, Hungerford DA: A minute chromosome in human chronic granulocytic leukemia. Science 132:1497, 1960
2. Kantarjian HM, Deisseroth AB, Kurzrock R, Estrov Z, Talpaz M: Chronic myelogenous leukemia: A concise update. Blood 82:691, 1993
3. Melo JV: The molecular biology of chronic myeloid leukaemia. Leukemia 10:751, 1996
4. Feinstein E, Cimino G, Gale RP, Alimena G, Berthier R, Kishi K, Goldman J, Zaccarai A, Berrebi A, Canaani E: p53 In chronic myelogenous leukemia in acute phase. Proc Natl Acad Sci USA 88:6293, 1991
5. Jennings B: A study of changes in methylation status and copy number at the c-myc locus during progression of chronic myeloid leukemia. Br J Haematol 89:37, 1995 (suppl 1)
6. Cogswell PC, Morgan R, Dunn M, Neubauer A, Nelson P, Poland-Johnston NK, Sandberg AA, Liu E: Mutations of the Ras proto-oncogenes in chronic myelogenous leukemia: A high frequency of Ras mutations in the bcr/abl rearrangement-negative chronic myelogenous leukemia. Blood 74:2629, 1989
7. Ahuja HG, Jat PS, Foti A, Bar-Eli M, Cline MJ: Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia. Blood 78:3259, 1991
8. Sill H, Goldman JM, Cross NCP: Homozygous deletions of the p16 tumor suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia. Blood 85:2013, 1995
9. Feinberg AP: Genomic imprinting and cancer, in Vogelstein B, Kinzler K (eds): The Genetics of Cancer. New York, NY, McGraw Hill Medical Publishing, 1998, p. 95
10. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP: Relaxation of imprinted genes in human cancer. Nature 362:747, 1993
11. KIP2 in Wilms' tumor. Cancer Res 56:5723, 1996
12. Steenman MJC, Rainier S, Dobry CJ, Grundy P, Horon IL, Feinberg AP: Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 methylation in Wilm's tumor. Nat Genet 7:433, 1994
13. Jinno Y, Sengoku K, Nakao M, Tmate K, Miyamato T, Matsuzaka T, Sutclifte JS, Anan T, Takuma N, Nishiwaki K, Ikeda Y, Ishimaru T, Ishikawa M, Niikawa N: Mouse/human sequence divergence in a region with a paternal-specific methylation imprint at the human H19 locus. Hum Mol Genet 5:1155, 1996
14. Reik W, Brown KW, Schneid H, Bouc YL, Bickmore W, Maher ER: Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by an altered imprinting pattern in the IGF2-H19 domain. Hum Mol Genet 4:2379, 1995
15. Reik W, Brown KW, Slatter RE, Sartori P, Elliot M, Maher ER: Allelic methylation of H19 and IGF2 in the Beckwith-Wiedemann Syndrome. Hum Mol Genet 3:1297, 1994
16. Nelkin BD, Przepiorka D, Burke PJ, Thomas ED, Baylin SB: Abnormal methylation of the calcitonin gene marks progression of chronic myelogenous leukemia. Blood 77:2431, 1991
17. Litz CE, Vos JA, Copenhaver CM: Aberrant methylation of the major breakpoint cluster region in chronic myeloid leukemia. Blood 88:2241, 1996
18. Zion M, Ben-Yehuda D, Avraham A, Cohen O, Wetzler M, Melloul D, Ben-Neriah Y: Progressive DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia. Proc Natl Acad Sci USA 91:10722, 1994
19. Wu H-K, Weksberg R, Minden MD, Squire JA: Loss of imprinting of human insulin like growth factor II gene, IGF2, in acute myeloid leukemia. Biochem Biophys Res Commun 231:466, 1997
20. KIP2, on chromosome 11p15. Proc Natl Acad Sci USA 93:3026, 1996
21. Hu R-J, Lee MP, Conners TD, Johnson LA, Burn TC, Su K, Landes GM, Feinberg AP: A 2.5 Mb transcript map of a tumor-suppressing subchromosomal transferable fragment from 11p15.5, and isolation and sequence analysis of three novel genes. Genomics 46:9, 1997
22. Lee MP, Feinberg AP: Genomic imprinting of a human apoptosis gene homologue, TSSC3. Cancer Res, in press
23. Nonomura N, Nishimura K, Miki T, Kanno N, Kojima Y, Yokoyama M, Okuyama A: Loss of imprinting of the insulin-like growth factor II gene in renal cell carcinoma. Cancer Res 57:2575, 1997
24. Weksberg R, Shen DR, Fei YL. Song QL, Squire J: Disruption of , insulin-like growth factor 2 imprinting in Beckwith-Weidemann syndrome. Nat Genet 5:143, 1993
25. Christofori G, Naik P, Hanahan D: Deregulation of both imprinted and expressed alleles of the insulin-like growth factor 2 gene during β-cell tumorigenesis. Nat Genet 10:196, 1995
26. KIP2, a cyclin-dependent kinase inhibitor, in mouse. Nat Genet 11:204, 1995